Back
X4 Pharmaceuticals, Inc. Stock Predictions
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
16
XFOR
X4 Pharmaceuticals, Inc.
Last Price:
$3.80
Seasonality Move:
14.77%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiX4 Pharmaceuticals, Inc. Stock Forecast
-
Is X4 Pharmaceuticals, Inc. Stock Undervalued?The current X4 Pharmaceuticals, Inc. [XFOR] share price is $3.25. The Score for XFOR is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
XFOR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will X4 Pharmaceuticals, Inc. Stock Go Up Next Year?
Data Unavailable
X4 Pharmaceuticals, Inc. Stock Rating
Data Unavailable
X4 Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
x4pharma.com
52-Week Data
52-Week High:
26.83
52-Week Low:
1.35
Prediction Charts
Market Cap:
284.2M
Price in USD:
3.25
Volume:
509K
Beta:
0.55
Technical Analysis
SMA50:
3.50
SMA100:
3.08
SMA200:
4.39
52-Wk Change:
-70.71%
Stock Predictions
-
Is X4 Pharmaceuticals, Inc. stock public?Yes, X4 Pharmaceuticals, Inc. is a publicly traded company.
-
What is the X4 Pharmaceuticals, Inc. stock quote today?The X4 Pharmaceuticals, Inc. stock price is 3.25 USD today.
-
How to buy X4 Pharmaceuticals, Inc. stock online?You can buy X4 Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 3.62 | 3.66 | 3.73 | 3.61 |
| Nov-17 | 3.64 | 3.66 | 3.86 | 3.61 |
| Nov-18 | 3.63 | 3.60 | 3.66 | 3.50 |
| Nov-19 | 3.60 | 3.65 | 3.79 | 3.50 |
| Nov-20 | 3.71 | 3.70 | 3.85 | 3.57 |
| Nov-21 | 3.73 | 3.75 | 3.78 | 3.57 |
| Nov-24 | 3.74 | 3.80 | 3.84 | 3.68 |
| Nov-25 | 3.83 | 3.80 | 3.90 | 3.78 |
| Nov-26 | 3.81 | 3.64 | 3.86 | 3.64 |
| Nov-28 | 3.68 | 3.64 | 3.82 | 3.62 |
| Dec-1 | 3.64 | 3.15 | 3.65 | 3.13 |
| Dec-2 | 3.17 | 3.20 | 3.32 | 3.13 |
| Dec-3 | 3.17 | 3.25 | 3.32 | 3.05 |
| Dec-4 | 3.25 | 3.80 | 3.81 | 3.25 |
X4 Pharmaceuticals, Inc. Earnings
Data Unavailable
X4 Pharmaceuticals, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.05 per share, and an increase next year of $1.33 per share.
* X4 Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.